Table 4.
Direct medical costs of three types of before and after, including patients in ICM (group ICM-yes) (in PLN and EUR) with results of Wilcoxon’s Matched-Pairs Signed-Rank test.
| Period | N | Mean | Median | Dominant | Dominant representation | Min. value | Max. value | p value |
|---|---|---|---|---|---|---|---|---|
| General costs | ||||||||
| Intro−6m | 41 | 5627.29 (≈1289.36EUR) | 3708.72 (»849.77 EUR) | 0 | 1 | 30.45 (≈6.98 EUR) | 29671.15 (≈6798.45 EUR) | 0.079114 |
| Intro+6m | 41 | 3576.79 (≈819.54 EUR) | 2388.4 (»547.25 EUR) | 0 | 2 | 0 | 16765.1 (≈3841.33 EUR) | |
| COPD and other respiratory system disease costs | ||||||||
| Intro−6m | 41 | 3191.43 (≈731.24EUR) | 2168.1 (»496.77 EUR) | 0 | 3 | 0 | 20071.54 (≈4598.92 EUR) | 0.012492 |
| Intro+6m | 41 | 1741.31 (≈398.98 EUR) | 157.5 (»36.09 EUR) | 0 | 6 | 0 | 9314.65 (≈2134.23 EUR) | |
| Exacerbation costs | ||||||||
| Intro−6m | 26 | 2443.61 (≈559.9EUR) | 1872 (»428.92EUR) | 0 | 7 | 0 | 20010.64 (≈4584.97EUR) | 0.017023 |
| Intro+6m | 26 | 735.17 (≈168.45EUR) | 0 | 0 | 18 | 0 | 5539.5 (≈1269.25EUR) | |